San Antonio, Texas

San Antonio, Texas 78240

2 studies enrolling now · 7 studies all time

What they study most

Alopecia Areata, BRVO - Branch Retinal Vein Occlusion, Branch Retinal Vein Occlusion (BRVO), Diabetic Macular Edema (DME), Hepatic Impairment, Idiopathic Hypersomnia, Narcolepsy Type 1, Narcolepsy Type 2, Neovascular Age-Related Macular Degeneration (NVAMD), Neovascular Age-related Macular Degeneration (NVAMD), Neurotrophic Keratopathy

Studies at this site

• A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO — Recruiting now
• A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia — Recruiting now
• A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration — Running, not enrolling
• A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA) — Running, not enrolling
• A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Emraclidine — Completed
• Phase 2 Clinical Trial to Evaluate OC-01 Nasal Spray in Subjects With Neurotrophic Keratopathy — Completed
• To Evaluate the Pharmacokinetics (PK) and Safety of Tavapadon in Participants With Mild and Moderate Hepatic Impairment Compared to Participants With Normal Hepatic Function — Completed